Oncology providers’ perspectives on endocrine therapy prescribing and management

PURPOSE: Adjuvant endocrine therapy (ET) can reduce the risk of recurrence among females with hormone receptor-positive breast cancer. Overall, initiation and adherence to ET are suboptimal, though reasons are not well described. The study’s objective was to better understand ET decision making, pre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Patient Prefer Adherence
Main Authors: Wheeler, Stephanie B, Roberts, Megan C, Bloom, Diane, Reeder-Hayes, Katherine E, Espada, Maya, Peppercorn, Jeffrey, Golin, Carol E, Earp, Jo Anne
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2016
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053382/
https://ncbi.nlm.nih.gov/pubmed/27757021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S95594
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares